SKI

SKI proto-oncogene, the group of SKI transcriptional corepressors

Basic information

Region (hg38): 1:2227388-2310213

Links

ENSG00000157933NCBI:6497OMIM:164780HGNC:10896Uniprot:P12755AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Shprintzen-Goldberg syndrome (Definitive), mode of inheritance: AD
  • Shprintzen-Goldberg syndrome (Strong), mode of inheritance: AD
  • Shprintzen-Goldberg syndrome (Strong), mode of inheritance: AD
  • Shprintzen-Goldberg syndrome (Strong), mode of inheritance: AD
  • Shprintzen-Goldberg syndrome (Definitive), mode of inheritance: AD
  • Shprintzen-Goldberg syndrome (Supportive), mode of inheritance: AD
  • Shprintzen-Goldberg syndrome (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Shprintzen-Goldberg craniosynostosis syndromeADCardiovascularIndividuals have been described with a number of cardiovascular anomalies, including aortic root dilatation, and spontaneous rupture of arterial aneurysms, and surveillance (eg, including echocardiogram) may allow early management, decreasing morbidity and mortalityCardiovascular; Craniofacial; Musculoskeletal; Neurologic23023332

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SKI gene.

  • Shprintzen-Goldberg_syndrome (878 variants)
  • Familial_thoracic_aortic_aneurysm_and_aortic_dissection (702 variants)
  • not_provided (333 variants)
  • not_specified (97 variants)
  • SKI-related_disorder (37 variants)
  • Intellectual_disability (5 variants)
  • Inborn_genetic_diseases (4 variants)
  • Neurodevelopmental_disorder (3 variants)
  • Isolated_thoracic_aortic_aneurysm (3 variants)
  • Disproportionate_tall_stature (2 variants)
  • See_cases (2 variants)
  • Craniosynostosis_syndrome (1 variants)
  • Autism_spectrum_disorder (1 variants)
  • Arterial_dissection (1 variants)
  • Cardiovascular_phenotype (1 variants)
  • Neurodevelopmental_abnormality (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SKI gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003036.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
503
clinvar
5
clinvar
513
missense
13
clinvar
16
clinvar
547
clinvar
98
clinvar
2
clinvar
676
nonsense
8
clinvar
8
start loss
1
1
frameshift
1
clinvar
2
clinvar
18
clinvar
21
splice donor/acceptor (+/-2bp)
1
clinvar
4
clinvar
5
Total 14 19 583 601 7

Highest pathogenic variant AF is 0.0000031012444

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SKIprotein_codingprotein_codingENST00000378536 781425
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
125412031254150.0000120
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.513494380.7960.00002884563
Missense in Polyphen93185.760.500651946
Synonymous-4.873002101.430.00001471536
Loss of Function4.40124.50.04090.00000123293

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.0001010.0000996
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001770.0000177
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May play a role in terminal differentiation of skeletal muscle cells but not in the determination of cells to the myogenic lineage. Functions as a repressor of TGF-beta signaling. {ECO:0000269|PubMed:19049980}.;
Disease
DISEASE: Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]: A very rare syndrome characterized by a marfanoid habitus, craniosynostosis, characteristic dysmorphic facial features, skeletal and cardiovascular abnormalities, mental retardation, developmental delay and learning disabilities. {ECO:0000269|PubMed:23023332, ECO:0000269|PubMed:23103230, ECO:0000269|PubMed:24357594, ECO:0000269|PubMed:24736733}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
TGF-Ncore;Olfactory bulb development and olfactory learning;TGF-beta Signaling Pathway;TGF-beta Receptor Signaling;Signal Transduction;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Notch;Downregulation of SMAD2/3:SMAD4 transcriptional activity;TGF-beta super family signaling pathway canonical;TGF_beta_Receptor;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;BMP receptor signaling;C-MYB transcription factor network;Signaling by TGF-beta Receptor Complex;Signaling by BMP;Signaling by TGF-beta family members;Regulation of nuclear SMAD2/3 signaling (Consensus)

Recessive Scores

pRec
0.152

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
1.00

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Zebrafish Information Network

Gene name
skia
Affected structure
bulbus arteriosus
Phenotype tag
abnormal
Phenotype quality
amorphous

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;neural tube closure;lens morphogenesis in camera-type eye;transcription, DNA-templated;transforming growth factor beta receptor signaling pathway;cell population proliferation;negative regulation of cell population proliferation;anterior/posterior axis specification;negative regulation of Schwann cell proliferation;myotube differentiation;olfactory bulb development;myelination in peripheral nervous system;positive regulation of Wnt signaling pathway;embryonic limb morphogenesis;BMP signaling pathway;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;negative regulation of histone deacetylation;negative regulation of activin receptor signaling pathway;somatic stem cell population maintenance;camera-type eye development;positive regulation of DNA binding;nose morphogenesis;negative regulation of cell differentiation;negative regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;negative regulation of fibroblast proliferation;camera-type eye morphogenesis;neuron development;skeletal muscle fiber development;cell motility;roof of mouth development;retina development in camera-type eye;face morphogenesis;bone morphogenesis;SMAD protein signal transduction;protein homotrimerization
Cellular component
nucleus;nucleoplasm;transcription factor complex;cytoplasm;centrosome;nuclear body;PML body;transcriptional repressor complex;protein-containing complex
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;transcription corepressor activity;protein binding;zinc ion binding;protein kinase binding;protein domain specific binding;ubiquitin protein ligase binding;SMAD binding;histone deacetylase inhibitor activity;repressing transcription factor binding
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.